Posted by Michael Wonder on 24 Apr 2018
EMA publishes agenda for 23-26 April CHMP meeting
23 April 2018 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue initial opinions for the following technologies:
- Masatinib mesylate
- Bictegravir sodium with emtricitabine and tenofovir alafenamide fumarate
- Carmustine
- Sufentanil
